SoniVie Raises $2.5M From Accelmed

November 2, 2015 | SoniVie has raised an additional $2.5 million from Israeli bio-medical fund Accelmed. Led by Assaf Bernstein, the company is developing a system for the treatment of pulmonary arterial hypertension – a severe disease that narrows the blood vessels connected to and within the lungs. The new financing will be used to fund the first in vivo trials.